Literature DB >> 19895256

Deliquescence of pharmaceutical systems.

Lisa J Mauer1, Lynne S Taylor.   

Abstract

Deliquescence is a first order phase transition from solid to solution that occurs at a relative humidity (RH) that is characteristic to the crystalline compound. Such dissolution of active pharmaceutical ingredients and excipients can lead to detrimental physical and chemical instabilities. Furthermore, in systems containing more than one deliquescent component, the RH of the solid-solution transition will be lowered, leading to some level of dissolution at unexpectedly low RH conditions. Deliquescence lowering is independent of the ratio of the deliquescent components and therefore is of concern for any formulation containing two or more deliquescent compounds. Because chemical reactions occur much more readily in solution, deliquescence will enhance the degradation of labile APIs. RH fluctuations will lead to cycles of deliquescence and efflorescence (crystallization), which will contribute to particle agglomeration and caking. This review will address the phenomenon of deliquescence, the significance of deliquescence to pharmaceutical systems, measurement techniques, the kinetics and thermodynamics of deliquescence, the behavior of mixtures of deliquescent compounds (including phase diagrams and thermodynamics of binary systems), and consequences of deliquescence on chemical and physical stability.

Mesh:

Substances:

Year:  2009        PMID: 19895256     DOI: 10.3109/10837450903397594

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  4 in total

1.  Water-solid interactions in amorphous maltodextrin-crystalline sucrose binary mixtures.

Authors:  Mohamed K Ghorab; Scott J Toth; Garth J Simpson; Lisa J Mauer; Lynne S Taylor
Journal:  Pharm Dev Technol       Date:  2013-03-12       Impact factor: 3.133

2.  Investigating the physical stability of repackaged medicines stored into commercially available multicompartment compliance aids (MCAs).

Authors:  Bahijja Tolulope Raimi-Abraham; Alba Garcia Del Valle; Carlota Varon Galcera; Susan Anne Barker; Mine Orlu
Journal:  J Pharm Health Serv Res       Date:  2017-05-08

3.  Additive manufacturing of prototype elements with process interfaces for continuously operating manufacturing lines.

Authors:  Cosima Hirschberg; Mikkel Schmidt Larsen; Johan Peter Bøtker; Jukka Rantanen
Journal:  Asian J Pharm Sci       Date:  2018-05-23       Impact factor: 6.598

4.  Organic deliquescence: organic vapor-induced dissolution of molecular salts.

Authors:  Kazuyuki Ishii; Kei Yokomori; Kei Murata; Seiji Nakamura; Kyoko Enomoto
Journal:  RSC Adv       Date:  2022-06-28       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.